Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Remaining areas of unmet need for patients with locally advanced pancreatic cancer

Rainer Fietkau, MD, PhD, University Hospital Erlangen, Erlangen, Germany, talks on the unmet needs of patients with locally advanced pancreatic cancer. 1/3 of this patient population will get distant metastases during induction chemotherapy, presenting a significant area for improvement. Prof. Rainer emphasizes the importance of obtaining an R0 resection for long-term survival and improving the selection criteria for patients undergoing surgery. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.